Innovent Announces Phase 2 Clinical Study of Higher dose 9 mg Mazdutide (IBI362) in Chinese Adults with Obesity Achieved the 24-Week Primary Endpoint May 10, 2023
Doceree forms an exclusive partnership with Hello Health Group to strengthen its global footprint; forays into 8 South East Asian markets May 10, 2023
Eleos Outreach brings AI-enabled click-to-text functionality to field-based clinicians’ EHRs May 1, 2023
Students use AI technology to find new brain tumor therapy targets — with a goal of fighting disease faster May 1, 2023
Bicara Therapeutics Announces Oral Presentation of Head and Neck Cancer Dose Expansion Data from Phase 1/1b Study of BCA101 at Upcoming 2023 ASCO Annual Meeting April 27, 2023
Insilico Medicine Successfully Discovered Potent, Selective, and Orally Bioavailable Small Molecule Inhibitor of CDK8 Using Generative AI April 24, 2023